@article{3126665,
    title = "Five-year experience with Ustekinumab for psoriasis: real-life data of a single centre",
    author = "Vergou, T. and Moustou, A.E. and Antoniou, C.",
    journal = "Journal of the European Academy of Dermatology and Venereology",
    year = "2017",
    volume = "31",
    number = "1",
    pages = "e40-e41",
    publisher = "Wiley-Blackwell Publishing Ltd",
    issn = "0926-9959, 1468-3083",
    doi = "10.1111/jdv.13658",
    keywords = "adalimumab;  cyclosporin;  efalizumab;  etanercept;  etretin;  infliximab;  methotrexate;  ustekinumab;  dermatological agent;  ustekinumab, adult;  basal cell carcinoma;  disease severity;  drug efficacy;  female;  human;  Letter;  major clinical study;  male;  medical record review;  middle aged;  non melanoma skin cancer;  priority journal;  psoriasis;  Psoriasis Area and Severity Index;  psoriatic arthritis;  pustulosis palmoplantaris;  remission;  squamous cell carcinoma;  thyroid cancer;  psoriasis, Dermatologic Agents;  Female;  Humans;  Male;  Middle Aged;  Psoriasis;  Ustekinumab"
}